XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders’ Equity
Common Stock
Class A Common Stock $0.001 Par Value
Common Stock
Class B Convertible Common Stock $0.001 Par Value
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2021 $ 1,145,527 $ 1,134,619 $ 100 $ 422 $ 1,350,457 $ (61,629) $ 3,309 $ (158,040) $ 10,908
Balance at beginning of period (in shares) at Dec. 31, 2021     99,745 422,019          
Increase (Decrease) in Shareholders' Equity                  
Net (loss) earnings (127,982) (128,450)       (128,450)     468
Other comprehensive income (loss) (5,028) (4,481)         (4,481)   (547)
Stock-based compensation expense 55,891 55,891     55,891        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (8,627) (8,627) $ 3   (8,630)        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)     3,066            
Purchase of treasury stock (8,144) (8,144)           (8,144)  
Adjustment to noncontrolling interests resulting from the reorganization of a foreign subsidiary (255) 7,580     7,580       (7,835)
Other (4) (4)     (4)        
Balance at end of period at Dec. 31, 2022 1,051,378 1,048,384 $ 103 $ 422 1,405,294 (190,079) (1,172) (166,184) 2,994
Balance at end of period (in shares) at Dec. 31, 2022     102,811 422,019          
Increase (Decrease) in Shareholders' Equity                  
Net (loss) earnings (40,311) (40,940)       (40,940)     629
Other comprehensive income (loss) 2,501 2,359         2,359   142
Stock-based compensation expense 48,388 48,388     48,388        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (6,288) (6,288) $ 4   (6,292)        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)     4,037            
Purchase of treasury stock (11,099) (11,099)           (11,099)  
Other (61) (37)     (37)       (24)
Balance at end of period at Dec. 31, 2023 1,044,508 1,040,767 $ 107 $ 422 1,447,353 (231,019) 1,187 (177,283) 3,741
Balance at end of period (in shares) at Dec. 31, 2023     106,848 422,019          
Increase (Decrease) in Shareholders' Equity                  
Net (loss) earnings 36,848 36,004       36,004     844
Other comprehensive income (loss) (3,544) (3,682)         (3,682)   138
Stock-based compensation expense 40,619 40,619     40,619        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (7,353) (7,353) $ 6   (7,359)        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)     6,104            
Purchase of treasury stock (28,581) (28,581)           (28,581)  
Purchase of noncontrolling interests (16,019) (11,296)     (11,296)       (4,723)
Other (3,677) (3,677)     (3,677)        
Balance at end of period at Dec. 31, 2024 $ 1,062,801 $ 1,062,801 $ 113 $ 422 $ 1,465,640 $ (195,015) $ (2,495) $ (205,864) $ 0
Balance at end of period (in shares) at Dec. 31, 2024     112,952 422,019